FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

377429002: Product containing precisely paracetamol 650 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3501702010 Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3501703017 Acetaminophen 650 mg and phenyltoloxamine citrate 50 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681759012 Product containing precisely paracetamol 650 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1202748012 Acetaminophen + phenyltoloxamine citrate 650mg/50mg tablet (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1215608014 Acetaminophen + phenyltoloxamine citrate 650mg/50mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1215608014 Acetaminophen + phenyltoloxamine citrate 650mg/50mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
1478788017 Acetaminophen+phenyltoloxamine citrate 650mg/50mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
2154784013 Paracetamol + phenyltoloxamine citrate 650mg/50mg tablet en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3470029015 Product containing acetaminophen 650 mg and phenyltoloxamine citrate 50 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3470030013 Product containing paracetamol 650 mg and phenyltoloxamine citrate 50 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3490488011 Product containing paracetamol 650 mg and phenyltoloxamine citrate 50 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3501702010 Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3501703017 Acetaminophen 650 mg and phenyltoloxamine citrate 50 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569347016 Product containing only paracetamol 650 mg and phenyltoloxamine citrate 50 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569348014 Product containing only acetaminophen 650 mg and phenyltoloxamine citrate 50 mg/1 each oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3569349018 Product containing only paracetamol 650 mg and phenyltoloxamine citrate 50 mg/1 each oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681759012 Product containing precisely paracetamol 650 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3681760019 Product containing precisely paracetamol 650 milligram and phenyltoloxamine citrate 50 milligram/1 each conventional release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Is a Product containing phenyltoloxamine (medicinal product) false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Ethanolamine false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Sedating antihistamine false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenyltoloxamine false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Is a Product containing paracetamol and phenyltoloxamine citrate false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Non-opioid analgesics false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. agent cardiovasculaire false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has manufactured dose form Conventional release oral tablet (dose form) true Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Is a Product containing paracetamol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has basis of strength substance (attribute) Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept) 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength numerator value 650 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has basis of strength substance (attribute) Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier (core metadata concept) 2
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength numerator unit (attribute) mg true Inferred relationship Existential restriction modifier (core metadata concept) 2
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength denominator value un false Inferred relationship Existential restriction modifier (core metadata concept) 2
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength denominator unit (attribute) Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept) 2
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier (core metadata concept) 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has basis of strength substance (attribute) Phenyltoloxamine citrate true Inferred relationship Existential restriction modifier (core metadata concept) 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength numerator value 50 false Inferred relationship Existential restriction modifier (core metadata concept) 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept) 2
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has basis of strength substance (attribute) Paracetamol true Inferred relationship Existential restriction modifier (core metadata concept) 2
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has presentation strength numerator value 650 false Inferred relationship Existential restriction modifier (core metadata concept) 2
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has precise active ingredient Phenyltoloxamine citrate false Inferred relationship Existential restriction modifier (core metadata concept) 2
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has precise active ingredient Paracetamol false Inferred relationship Existential restriction modifier (core metadata concept) 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has unit of presentation Tablet (unit of presentation) true Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Is a Product containing paracetamol and phenyltoloxamine in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Count of base of active ingredient deux false Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Is a Product containing only paracetamol and phenyltoloxamine in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier (core metadata concept)
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has precise active ingredient Phenyltoloxamine citrate true Inferred relationship Existential restriction modifier (core metadata concept) 1
Paracetamol 650 mg and phenyltoloxamine citrate 50 mg oral tablet Has precise active ingredient Paracetamol true Inferred relationship Existential restriction modifier (core metadata concept) 2
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start